CLINICAL EVALUATION OF TRAUMATICITY OF DIFFERENT ENERGY TYPES USED IN THE SURGICAL TREATMENT OF BENIGN OVARIAN TUMORS

Objective. To study the efficiency of using argon plasma coagulation (APC) versus bipolar coagulation (BC) in patients with benign ovarian tumors (BOT). Subject and methods. The prospective study enrolled 110 patients with BOT surgically treated by BC or APC. The diagnostic value of clinical criteria (motor activity; recovery of urination and intestinal motility; temperature and pain responses; blood clinical test; C-reactive protein) and biochemical specific markers (middle-weight molecules; acid-soluble fractions of nuclei acids; active products of interaction with thiobarbituric acid) was studied to evaluate the severity of a surgical intervention. Results. A scale was constructed to rate traumaticity of surgical intervention using BC and APC for BOT. Significant differences in the clinical criteria and biochemical markers of surgical intervention were found in patients surgically treated using different types of energy. APC in patients with benign ovarian tumors showed low and moderate traumaticity in 27 (45%) and 33 (55%) cases, respectively (p<0.05). When BC was applied, these were in 14 (28%) and 36 (72%) cases, respectively (p<0.05). Thus, after APC there were 1.6 times more and 1.3 times fewer patients with low and moderate traumaticity than those following BC. Conclusion. Analyzing the traumaticity of laparoscopic intervention in patients with benign ovarian tumors, by applying the constructed scale has indicated that when the protocol is optimally used, APC is less traumatic (aggressive) than BC.

benign ovarian tumours, argon plasma coagulation, laparoscopy, the destruction of tissue products